CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- 4 Planned sale EVP, CFO & CBO sold 8,224 shares at $89.84 ($738,844)
- 4 Planned sale EVP, CFO & CBO sold 114,367 shares at an average $83.00 ($9,492,596)
- 4 Planned sale Director sold 599 shares at $80.11 ($47,986)
- 4 Planned sale Director sold 27,594 shares at $78.05 ($2,153,712)
- 4 Option exercise CEO AND PRESIDENT acquired 65,292 shares (option exercise)
- 4 Planned sale CEO AND PRESIDENT sold 122,918 shares at an average $81.49 ($10,016,381)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 43,682 shares at an average $81.49 ($3,559,495)
- 4 Planned sale EVP, Head of R&D sold 33,830 shares at $81.48 ($2,756,468)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CFO & CBO sold 20,000 shares at $45.18 ($903,600)
- 4 Planned sale EVP, Head of R&D sold 196,538 shares at an average $37.55 ($7,379,887)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CFO & CBO sold 20,000 shares at $35.00 ($700,000)
- 4 Derivatives Options or other derivatives
Page 2 of 15 · 290 filings